0001214659-18-005459.txt : 20180814 0001214659-18-005459.hdr.sgml : 20180814 20180814132443 ACCESSION NUMBER: 0001214659-18-005459 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180814 DATE AS OF CHANGE: 20180814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL HEALTH FARM HOLDINGS INC CENTRAL INDEX KEY: 0001621697 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 611744532 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-199478 FILM NUMBER: 181016005 BUSINESS ADDRESS: STREET 1: 20 NORTH ORANGE AVE. STREET 2: SUITE 1100 CITY: ORLANDO STATE: FL ZIP: 32801 BUSINESS PHONE: 407-476-8976 MAIL ADDRESS: STREET 1: 20 NORTH ORANGE AVE. STREET 2: SUITE 1100 CITY: ORLANDO STATE: FL ZIP: 32801 FORMER COMPANY: FORMER CONFORMED NAME: AMBER GROUP INC DATE OF NAME CHANGE: 20141007 10-Q 1 n81018310q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2018

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to ______________

Commission File No. 000-1621697

NATURAL HEALTH FARM HOLDINGS INC.

(Exact name of small business issuer as specified in its charter)

NEVADA				98-1032170
(State or other jurisdiction of incorporation or organization)				(I.R.S. Employer Identification No.)

20 North Orange Avenue, Suite 1100

Orlando, Florida 32801

(Address of principal executive offices)

(407) 476-8976

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The number of shares of Common Stock, $0.001 par value, of the registrant outstanding at August 14, 2018 was 161,405,000.

TABLE OF CONTENTS

		Page No.
PART I.

Item 1. Financial Statements.		1

	Condensed Balance Sheets as of June 30, 2018 (Unaudited) and September 30, 2017	1

	Condensed Statements of Operations for the Three Months and Nine Months ended June 30, 2018 and 2017 (Unaudited)	2

	Condensed Statements of Cash Flows for the Nine Months ended June 30, 2018 and 2017 (Unaudited)	3

	Notes to Unaudited Condensed Financial Statements	4

	Item 2. Management’s Discussion and Analysis or Plan of Operation	11

	Item 3. Quantitative and Qualitative Disclosures About Market Risks.	13

	Item 4. Controls and Procedures	14

PART II.

	Item 1. Legal Proceedings.	15

	Item 1A. Risk Factors.	15

	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.	15

	Item 3. Defaults Upon Senior Securities.	15

	Item 4. Mine Safety Disclosures.	15

	Item 5. Other Information.	15

	Item 6. Exhibits.	15

SIGNATURES		16

EXHIBIT INDEX		17

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (“Form 10-Q”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new products or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties.

Forward-looking statements may include the words “may,” “could,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect,” “desire,” “goal,” “should,” “objective,” “seek,” “plan,” “strive” or “anticipate,” as well as variations of such words or similar expressions, or the negatives of these words. These forward-looking statements present our estimates and assumptions only as of the date of this Form 10-Q. Except for our ongoing obligation to disclose material information as required by the federal securities laws, we do not intend, and undertake no obligation, to update any forward-looking statement. We caution readers not to place undue reliance on any such forward-looking statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes will likely vary materially from those indicated.

PART I.

Item 1. Financial Statements.

NATURAL HEALTH FARM HOLDINGS INC.

CONDENSED BALANCE SHEETS

	June 30, 2018			September 30, 2017
ASSETS	(Unaudited)

Current Assets
Cash and cash equivalents	$	46,992		$	-
Prepaid expense		4,600			-
Total Current Assets		51,592			-

Computer Software, net		34,268			-

Total Assets	$	85,860		$	-

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities
Accounts payable	$	11,627		$	-
Accrued expense		4,219			2,070
Deferred revenue - related party		63,924			-
Deferred revenue - third party		53,861			-
Payable to affiliate		98,837			78,067
Note payable		40,000			-
Advance from director		500			-
Total Current Liabilities		272,968			80,137

Total Liabilities		272,968			80,137

Commitments and Contingencies (Note 9)

Stockholders' Deficit

Common Stock, $0.001 par value, 500,000,000 shares authorized, 161,405,000 shares and 150,150,000 shares issued and outstanding at June 30, 2018 and September 30, 2017, respectively		161,405			150,150
Additional Paid in Capital		558,993			(111,821	)
Stock subscriptions receivable		(10,050	)		-
Accumulated Deficit		(897,456	)		(118,466	)
Total Stockholders' Deficit		(187,108	)		(80,137	)

Total Liabilities and Stockholders' Deficit	$	85,860		$	-

The accompanying notes are an integral part of these unaudited condensed financial statements.

NATURAL HEALTH FARM HOLDINGS INC.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the Three Months Ended June 30,						For the Nine Months Ended June 30,
	2018			2017			2018			2017

Revenues - related party	$	6,583		$	-		$	15,076		$	-
Revenues - non-related party		5,167			-			8,139			-
Total Revenues		11,750			-			23,215			-

Cost of Goods Sold		3,488			-			7,582			-

Gross Profit		8,262			-			15,633			-

Operating Expenses:
Consulting fees		109,626			-			145,240			-
Legal and filing fees		12,130			6,738			35,845			8,643
Professional fees		5,650			19,052			5,650			19,052
Loan commitment fee		40,000			-			40,000			-
Stock compensation		526,295			-			526,295			-
Other general and administrative		33,227			-			41,374			7,240
Total Operating Expenses		726,928			25,790			794,404			34,935

Loss from Operations		(718,666	)		(25,790	)		(778,771	)		(34,935	)

Other Income (Expense)		(219	)		-			(219	)		-

Loss Before Provision For Income Tax		(718,885	)		(25,790	)		(778,990	)		(34,935	)

Provision for Income Tax		-			-			-			-

Net Loss	$	(718,885	)	$	(25,790	)	$	(778,990	)	$	(34,935	)

Basic and Dilutive Net Loss Per Share	$	(0.00	)	$	(0.00	)	$	(0.01	)	$	(0.00	)

Weighted Average Number of Shares Outstanding - Basic and Diluted		156,201,374			150,150,000			152,379,579			150,150,000

The accompanying notes are an integral part of these unaudited condensed financial statements.

NATURAL HEALTH FARM HOLDINGS INC.

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	For the Nine Months Ended June 30,
	2018			2017
Cash Flows from Operating Activities:
Net Loss	$	(778,990	)	$	(34,935	)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities
Amortization of computer software costs		7,582			-
Loan commitment fee		40,000			-
Common stock issued to consultants for services		105,000			-

Stock compensation expense upon grant of stock options		526,295
Changes in operating assets and liabilities
(Increase) decrease in prepaid expense		(4,600	)		696
Increase in accounts payable		11,627			-
Increase in accrued expense		2,149			2,070
Increase in deferred revenue - related party		63,924			-
Increase in deferred revenue - third party		53,861			-
Net Cash Flows Provided by (Used in) Operating Activities		26,848			(32,169	)

Cash Flows from Investing Activities
Purchase of computer software		(41,850	)		-
Net Cash Flows Used in Investing Activities		(41,850	)		-

Cash Flows from Financing Activities
Cash proceeds from affiliate		20,770			-
Cash advance from director		500			-
Cash proceeds from sale of common shares		260			-
Cash proceeds from stock subscriptions		40,464			-
Net Cash Flows Provided by Financing Activities		61,994			-

Net Increase in Cash and Cash Equivalents		46,992			(32,169	)

Cash and Cash Equivalents, Beginning of the Period		-			-

Cash and Cash Equivalents, End of the Period	$	46,992		$	-

Supplemental Disclosures of Cash Flow Information:
Cash paid for Income Taxes	$	-		$	-
Cash paid for Interest	$	-		$	-

Supplemental disclosures of non-cash investing and financing activities:
Stock issued for subscriptions receivable	$	10,050		$	-

The accompanying notes are an integral part of these unaudited condensed financial statements.

NATURAL HEALTH FARM HOLDINGS INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2018

(UNAUDITED)

NOTE 1 – NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN

Natural Health Farm Holdings Inc. (the “Company”, “We”, “Its”, and “NHFH”) was incorporated under the laws of the State of Nevada on July 10, 2014 (Inception date). The Company has developed web-based business and launched itself into the healthcare industry. The Company has plans to provide through its subsidiaries, retail nutritional supplements, organic foods, personal care, and other health care products. The Company currently provides nutritional consulting services by offering a web based naturopathic learning management system that allows distributors, chiropractors and consumers to educate users products with the health-related aspects of various illnesses, and how the Company’s learning systems could be used to improve their general wellbeing.

On November 30, 2016, the Company filed a certificate of amendment to its articles of incorporation with the Nevada Secretary of State to change its name from Amber Group Inc. to Natural Health Farm Holdings Inc. The Company effectuated a 30:1 forward stock split of its common stock and increased its authorized share capital to 500,000,000 (Five Hundred Million) shares. This amendment was unanimously approved by the Company’s board of directors on November 29, 2016 and with the stockholders holding a majority of the Company’s voting power.

On March 16, 2017, Financial Industry Regulatory Authority (FINRA) approved the corporate name change to Natural Health Farm Holdings Inc., approved the increase in the Company’s authorized shares of common stock to 500,000,000 shares, and approved 30:1 forward stock split effective March 17, 2017, and provided us a trading symbol for our common stock as “NHEL”.

Basis of Presentation

The accompanying interim condensed financial statements are unaudited, but in the opinion of management of the Company, contain all adjustments, which include normal recurring adjustments necessary to present fairly the financial position at June 30, 2018, and the results of operations for three months and nine months ended June 30, 2018, and cash flows for the nine months ended June 30, 2018 and 2017. The balance sheet as of September 30, 2017 is derived from the Company’s audited financial statements.

Certain information and footnote disclosures normally included in financial statements that have been prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission, although management of the Company believes that the disclosures contained in these interim condensed financial statements are adequate to make the information presented therein not misleading. For further information, refer to the financial statements and the notes thereto contained in the Company’s September 30, 2017 Annual Report filed with the Securities and Exchange Commission on Form 10-K on December 28, 2017.

Going Concern

The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has generated small revenues and has sustained cumulative operating losses since July 10, 2014 (Inception Date) to date and allow it to continue as a going concern. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders and affiliates, the ability of the Company to obtain necessary financing to continue operations, and the attainment of profitable operations. The Company has recorded a net loss of $778,990 from October 1, 2017 to June 30, 2018, provided net cash flows in operating activities of $26,848, has a working capital deficit of $221,377, and has an accumulated deficit of $897,456 as of June 30, 2018. The Company has had difficulty in obtaining working capital lines of credit from financial institutions and trade credit from vendors. These factors, among others, raise a substantial doubt regarding the Company’s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The following summary of significant accounting policies of the Company is presented to assist in the understanding of the Company’s financial statements. The financial statements and notes are the representation of the Company’s management who is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America (“GAAP”) in all material respects and have been consistently applied in preparing the accompanying financial statements.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related party. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Cash and Cash Equivalents

The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. The Company had a cash balance of $46,992 at June 30, 2018 and $0 at September 30, 2017, respectively.

Prepaid Expenses

Prepaid expenses represent payments made by the Company in advance for which the services have not been received. The Company recorded $4,600 and $0 in prepaid expense at June 30, 2018 and September 30, 2017, respectively.

Computer Software Costs

Computer software costs include direct costs incurred for purchase of developed software products and payments made to independent software developers. The Company accounts for computer software costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Computer software costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Computer software costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to computer software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation.

Commencing upon product release, capitalized computer software costs are amortized on the straight-line method over a thirty-six months period. The Company evaluates the future recoverability of capitalized computer software costs on an annual basis.

Revenue Recognition

The Company generates revenue from licensing and other software services from its web-based software to distributors and retailers of nutritional supplements in the healthcare industry. The Company recognize licensing fees and other software services as revenue over the period of the contract at the time that the computer software is delivered and accepted by the customer, the selling price is fixed, and collection is reasonably assured, provided no significant obligations remain. The Company considers authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting.

Deferred revenues represent billings or cash received in excess of revenue recognizable on service agreements that are not accounted for as revenues.

Concentration of Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company does not have the cash balances in excess of Federal Deposit Insurance Corporation limit at June 30, 2018 and September 30, 2017, respectively.

Income Taxes

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions.” When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying condensed balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

Earnings (Loss) Per Common Share

The Company computes net earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted net earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. At June 30, 2018 and September 30, 2017, there were options granted to certain employees and independent consultants that when vested convert into 450,000 shares of common stock. At June 30, 2018 and September 30, 2017, there were no convertible notes, warrants available for conversion that if exercised, may dilute future earnings per share.

Fair value of Financial Instruments and Fair Value Measurements

ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company’s financial instruments consist principally of cash, accounts payable, accrued expenses and payable to an affiliate. Pursuant to ASC 820, “Fair Value Measurements and Disclosures” and ASC 825, “Financial Instruments”, the fair value of our cash equivalents is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The Company believes that the recorded values of all the other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

The following table presents assets and liabilities that were measured and recognized at fair value as of June 30, 2018 on a recurring basis:

Description

Level 1

Level 2

Level 3

None

The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:

Description

Level 1

Level 2

Level 3

None

Recent Accounting Pronouncements

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses (Topic 326).” The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. This ASU is effective for financial statements issued for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements.

In 2015, the FASB issued ASU No. 2015-17, “Income Taxes” (Topic 740): Balance Sheet Classification of Deferred Taxes, which requires all deferred tax assets and liabilities to be classified as noncurrent in a classified balance sheet. Current US GAAP requires an entity to separate deferred tax assets and liabilities into current and noncurrent amounts in a classified balance sheet. For public entities, ASU 2015-17 is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, ASU 2015-17 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018, and may be applied either prospectively or retrospectively, with early application permitted for financial statements that have not been previously issued. The Company has not yet determined the effect of the adoption of this standard on the Company’s financial position and results of operations.

NOTE 3 – PREPAID EXPENSE

The Company recorded prepaid expense of $4,600 and $0 at June 30, 2018 and September 30, 2017. Prepaid expense consisted of $4,000 relating to legal fees and $600 for stock transfer agent fees, paid in advance as of June 30, 2018. No prepayments of expenses were made as of September 30, 2017.

NOTE 4 – COMPUTER SOFTWARE COSTS

The Company purchased web-based naturopathic learning management system computer software, developed by a third party, to educate users with the health-related products for various illnesses, and how the Company’s learning systems could be used to improve their general wellbeing. The amount capitalized include direct costs incurred in developing the software purchased from the third party.

The following table presents details of our computer software costs as of June 30, 2018 and September 30, 2017:

Balance at

September 30, 2017

Additions

Amortization

Balance at

June 30, 2018

Computer Software Costs, net

41,850

(7,582

)

34,268

Computer software costs are being amortized on a straight-line basis over their estimated life of three years.

Amortization expense for computer software costs was $3,488 and $0 for the three months ended June 30, 2018 and 2017, and $7,582 and $0 for the nine months ended June 30, 2018 and 2017, respectively.

The estimated future amortization expense of computer software costs as of June 30, 2018 is as follows:

Year ending September 30,	Amount
2018	$	3,488
2019		13,950
2020		13,950
2021		2,880
Total	$	34,268

NOTE 5 – ACCOUNTS PAYABLE

Accounts payable at June 30, 2018 and September 30, 2017 totaled $11,627 and $0, respectively. Accounts payable consisted of $11,627 and $0 in legal and consulting fees payable as of June 30, 2018 and September 30, 2017, respectively.

NOTE 6 – PAYABLE TO AFFILIATES

The Company has received an advance of $500 from a director for its working capital needs as of June 30, 2018 (see NOTE 7).

The Company has received advances from an affiliate for its working capital needs from an entity in which its Chief Executive Officer is also a director in such entity (NOTE 6). The advance received is non-interest bearing, unsecured and payable on demand is summarized as follows.

	Balance June 30, 2018		Balance September 30,2017
		(Unaudited)
Payable to affiliate	$	98,837	$	78,067
Total	$	98,837	$	78,067

NOTE 7 – RELATED PARTY TRANSACTIONS

The Company received an advance of $500 and $0 from a director for its working capital needs as of June 30, 2018 and September 30, 2017, respectively. Funds advanced to the Company by the director are non-interest bearing, unsecured and due on demand (NOTE 6).

The Company has received advances for its working capital needs from an affiliate in which the Company’s Chief Executive Officer holds the position of director in such entity (see NOTE 6).

On November 20, 2017, the Company sold ten (10) naturopathic learning management system and modules for $29,000 to an entity solely owned by a director of the Company. The Company received the payment in full of $29,000 on December 21, 2017. The Company recorded $2,417 and $5,886 as revenues earned for the three months and nine months ended June 30, 2018, and $23,114 as deferred revenues at June 30, 2018.

On December 11, 2017, the Company sold twenty (20) naturopathic learning management systems and modules for $50,000 to an entity in which the Company Chief Executive Officer holds the position of director in such entity. The Company received the payment of $50,000 on December 28, 2017. The Company recorded $4,167 and $9,190 as revenues earned for the three months and nine months ended June 30, 2018 and $40,810 as deferred revenues at June 30, 2018.

On May 30, 2018, the Company granted stock options to three officers/directors to purchase 250,000 shares of common stock at exercise price of $1.50 per share over a five (5) years term.

NOTE 8 – EQUITY FINANCING AGREEMENT AND NOTE PAYABLE

Note payable consist of:

	June 30, 2018		September 30, 2017
		(Unaudited)
Note payable - GHS Investments, Inc.	$	40,000	$	-
Total		40,000		-

Current portion	$	40,000	$	-

On June 5, 2018, the Company entered into an Equity Financing Agreement and Registration Rights Agreement with GHS Investments Inc. (“GHS”) pursuant to which GHS agreed to purchase up to $20,000,000 in shares of Company common stock. The obligations of GHS to purchase the shares of Company common stock are subject to the conditions set forth in the Equity Financing Agreement, including, without limitation, the condition that a registration statement on Form S-1 registering the shares of Company common stock to be sold to GHS be filed with the Securities and Exchange Commission and become effective. The Registration Rights Agreement provides that the Company shall use commercially reasonable efforts to file the registration statement within 30 days after the date of the Registration Rights Agreement and have the registration statement become effective within 90 days after it is filed. In connection with the Equity Financing Agreement, the Company executed a promissory note in the principal amount of $40,000 (the “Note”) as payment of the commitment fee for the Equity Financing Agreement. The Note bears interest at the rate of 8% and must be repaid on or before March 5, 2019. The Company has recorded the commitment fee as an expense in the accompanying statements of operations for the nine months ended June 30, 2018. The Company has accrued the interest expense of $219 on the principal balance of $40,000 for the period from June 5, 2018 to June 30, 2018.

NOTE 9 – COMMITMENTS AND CONTINGENCIES

Litigation Costs and Contingencies

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Other than as set forth below, management is currently not aware of any such legal proceedings or claims that could have, individually or in the aggregate, a material adverse effect on our business, financial condition, or operating results.

In the normal course of business, the Company incurs costs to hire and retain external legal counsel to advise it on regulatory, litigation and other matters. The Company expenses these costs as the related services are received. If a loss is considered probable and the amount can be reasonable estimated, the Company recognizes an expense for the estimated loss.

NOTE 10: STOCKHOLDERS’ DEFICIT

The Company’s capitalization at June 30, 2018 was 500,000,000 authorized common shares with a par value of $0.001 per share.

Common Stock

On November 30, 2016, the Company increased the authorized share capital from 75,000,000 shares of common stock to 500,000,000 shares of common stock. In addition, the Company effectuated a 30:1 forward stock split of the common stock on such date.

On February 1, 2018, the Company entered into consulting agreements with two contractors for providing business advisory and consulting services. The Company issued 1,000,000 shares of common stock valued at $20,000 as the fair market value of the stock.

On March 1, 2018, the Company entered into a Share Exchange Agreement (the “Agreement”) with its shareholders whereby, the shareholders agreed to exchange, sell, convey, transfer and assign to the Company their shareholdings, free and clear of all liens, pledges, encumbrances, changes, restrictions or known claims of any kind, nature or description plus pay to the Company an aggregate purchase price of $50 (the “Purchase Price”), and the Company agreed to accept from its shareholders the old shares plus the Purchase Price in exchange for the transfer of old shares the new shares. As of June 30, 2018, the Company received cash proceeds of $40,464 from its shareholders to exchange the old shares for new shares and recorded it as contributed capital in the accompanying financial statements.

On May 16, 2018, the Company issued 50,000 shares of its common stock for a cash consideration of $50 pursuant to an agreement dated February 15, 2018. In addition, on the same date, the Company issued 105,000 shares of common stock for a cash consideration of $210 pursuant to an agreement dated March 1, 2018. The common shares issued were valued at the fair value on the date of execution of the agreement to issue such shares.

On May 16, 2018, the Company issued 10,050,000 shares of common stock for a cash consideration of $10,050 pursuant to an agreement dated March 1, 2018. The common shares were valued at $10,050 being their fair value on the date of execution of the agreement. The Company recorded $10,050 as subscriptions receivable as of June 30, 2018 since the Company did not receive the cash proceeds for stock subscriptions.

On June 21, 2018, the Company issued 50,000 shares of common stock to a consultant pursuant to an agreement, for providing consulting and business advisory services to the Company. The common shares were valued at $85,000 being their fair value on the date of execution of the agreement to issue such shares.

As a result of all common stock issuances, the Company had 161,405,000 shares and 150,150,000 shares of common stock issued and outstanding at June 30, 2018 and September 30, 2017, respectively.

Stock Option Plan

On May 30, 2018, the Board of Directors authorized and approved the 2018 Non-Qualified Stock Option Plan (the “2018 Plan) and reserved 10,000,000 shares of the Company’s common stock intended to be issued to selected officers, directors, consultants and key employees provided that bona fide services shall be rendered by such consultants or advisors and such services must not be in connection with the offer or sale of securities in a capital-raising transaction and do not promote or maintain a market for the Company’s securities. The Company filed a Registration Statement with the SEC on May 31, 2018 disclosing formation of 2018 Plan.

On May 30, 2018, the Board granted stock options under the 2018 Plan to two directors, an officer and an employee, and three independent consultants to purchase up to 450,000 shares of common stock with a five-year term. The stock options vested immediately upon the issuance date. The exercise price of the stock options to purchase common stock was at $1.50 per share, and the quoted market price of the Company stock on the grant date was $1.70. The option to purchase common stock expires on May 30, 2023. The fair value of options granted was $526,295, calculated using Black-Scholes option pricing model using the assumptions of risk free discount rate of 2.79%, volatility of 106%, 2.5 year-term for employees and directors and 5 year-term for non-employees, and dividend yield of 0%. The Company has recorded stock compensation expense of $526,295 for the three months and nine months ended June 30, 2018.

NOTE 11 – SUBSEQUENT EVENTS

Management has evaluated subsequent events through August 14, 2018, the date the financial statements were available to be issued, noting no new transactions that would require additional disclosure.

Item 2.

Management’s Discussion and Analysis or Plan of Operation

This Quarterly Report Form 10-Q contains forward-looking statements. Our actual results could differ materially from those set forth as a result of general economic conditions and changes in the assumptions used in making such forward-looking statements. The following discussion and analysis of our financial condition and results of operations should be read together with the unaudited condensed financial statements and accompanying notes and the other financial information appearing elsewhere in this report. The analysis set forth below is provided pursuant to applicable Securities and Exchange Commission regulations and is not intended to serve as a basis for projections of future events.

Natural Health Farm Holdings Inc., incorporated in the State of Nevada on July 10, 2014 (inception date), has developed and launched itself into the healthcare industry. The Company has plans to provide through its subsidiaries, retail nutritional supplements, organic foods, personal care, and other health care products. The Company is currently providing nutritional consulting services by offering a web based naturopathic learning management system that allows distributors, chiropractors and consumers to educate users with the health products related to various illnesses, and how the Company’s educational platform could be used to improve their general wellbeing.

From inception, through the date of this quarterly report, we reported revenues and incurred expenses and accumulated operating losses, as part of our development activities. We recorded a net loss of $778,990 for the nine months ended June 30, 2018, working capital deficiency of $221,377, and an accumulated deficit of $897,456 at June 30, 2018.

We anticipate that we will need substantial working capital over the next 12 months to continue as a going concern and to expand our operations to distribute, sell and market naturopathic learning management system together with online learning courses. Our independent auditors have expressed substantial doubt as to the ability of the Company to continue as a going concern. Unless we are able to generate sufficient cash flows from operations and/or obtain additional financing, there is a substantial doubt as to the ability of the Company to continue as a going concern. We intend to make an equity offering of our common stock for the acquisition and operation expenses. If we cannot raise the required cash, we will issue additional shares of our common stock in lieu of cash.

Results of Operations

Our results of operations for the three months ended June 30, 2018 and 2017 included the operations of the Company. We reported a net loss of $718,885 and a loss of $25,790 applicable to the Company’s common stockholders for the three months ended June 30, 2018 and 2017, respectively.

Our results of operations for the nine months ended June 30, 2018 and 2017 included the operations of the Company. We reported a net loss of $778,990 and a net loss of $34,935 for the nine months ended June 30, 2018 and 2017, respectively.

Revenue and Cost of Goods Sold

For the three months ended June 30, 2018 and 2017, we recorded total revenues of $11,750 ($6,583 from related parties and $5,167 from third parties) and $0, respectively. Revenues recorded were from licensing fees and other software related revenues relating to web-based naturopathic learning management system and training provided to four customers. Cost of goods sold recorded represents the amortization cost of the web-based software purchased from a third party for the three months ended June 30, 2018 and 2017. Cost of goods sold recorded was $3,488 and $0 for the three months ended June 30, 2018 and 2017, respectively.

For the nine months ended June 30, 2018, and 2017, we recorded total revenues of $23,215 ($15,076 from related parties and $8,139 from third parties) and $0, respectively. Revenues recorded were from licensing fees and other software related revenues relating to web-based naturopathic learning management system and training provided to two customers and two related party affiliates in which our directors also hold the directors’ position. Cost of goods sold of $7,582 and $0 recorded represents the amortization cost of the web-based software purchased from a third party for the nine months ended June 30, 2018 and 2017, respectively.

Operating Expenses

Operating expenses for the three months ended June 30, 2018 and 2017 were $726,928 and $25,790, respectively. Operating expenses for the three months ended June 30, 2018 consisted of the Company recording $40,000 expense as loan commitment fee payable to a third party pursuant to an equity financing arrangement, consulting fees of $109,626 payable to consultants and business advisors for services, stock compensation expense of $526,295 for grant of options to employees, directors and consultants, $14,500 in dues and subscriptions for being a public company, and $12,130 in legal and filing fees. Operating expenses for the three months ended June 30, 2017 consisted of $19,052 in fees paid to professional consultants and business advisors for services and $6,738 in legal and filing fees for being a public company.

Operating expenses for the nine months ended June 30, 2018 and 2017 were $794,404 and $34,935, respectively. Operating expenses for the nine months ended June 30, 2018 consisted of the Company engaging outside consultants and business advisors for consulting fees totaling $145,240, loan commitment fees of $40,000 pursuant to equity financing agreement, legal and filing fees of $35,845 upon becoming a public reporting entity, stock compensation expense of $526,295 for grant of stock options to employees, directors and consultants, and $14,500 in dues and subscriptions for being a public company. Operating expenses for the nine months ended June 30, 2017 consisted of $19,052 in expenses for professional fees, $8,643 in filing fees for being a public company, and $7,240 for auditor’s fees.

Liquidity and Capital Resources

Cash and cash equivalents were $46,992 at June 30, 2018 as compared to $0 at September 30, 2017. As reported in the accompanying financial statements, we recorded a net loss of $778,990 for the nine months ended June 30, 2018. Our working capital deficit and accumulated deficit at June 30, 2018 was $221,377 and $897,456, respectively. These factors and our ability to raise additional capital to accomplish our objectives, raises doubt about our ability to continue as a going concern. We expect our expenses will continue to increase during the foreseeable future as a result of increased operational expenses and the development of our current business operations. We anticipate generating only minimal revenues over the next twelve months. Consequently, we are dependent on the proceeds from future debt or equity investments to sustain our operations and implement our business plan. If we are unable to raise sufficient capital, we will be required to delay or forego some portion of our business plan, which would have a material adverse effect on our anticipated results from operations and financial condition. There is no assurance that we will be able to obtain necessary amounts of capital or that our estimates of our capital requirements will prove to be accurate.

We presently do not have any significant credit available, bank financing or other external sources of liquidity. Due to our accumulated operating losses, our operations have not been a source of liquidity. We will need to acquire other profitable entities or obtain additional capital in order to expand operations and become profitable. In order to obtain capital, we may need to sell additional shares of our common stock or borrow funds from private lenders. There can be no assurance that we will be successful in obtaining additional funding.

To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities may result in dilution to existing stockholders. If additional funds are raised through the issuance of debt securities, these securities may have rights, preferences and privileges senior to holders of common stock and the terms of such debt could impose restrictions on our operations. Regardless of whether our cash assets prove to be inadequate to meet our operational needs, we may seek to compensate providers of services by issuance of stock in lieu of cash, which may also result in dilution to existing shareholders. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing.

No assurance can be given that sources of financing will be available to us and/or that demand for our equity/debt instruments will be sufficient to meet our capital needs, or that financing will be available on terms favorable to us. If funding is insufficient at any time in the future, we may not be able to take advantage of business opportunities or respond to competitive pressures or may be required to reduce the scope of our planned service development and marketing efforts, any of which could have a negative impact on our business and operating results.

Operating Activities

Net cash flows provided by operating activities for the nine months ended June 30, 2018 was $26,848 which resulted primarily from our net loss of $831,229, amortization of software costs of $7,582, loan commitment fees of $40,000, common stock valued at $105,000 issued to consultants for business advisory services, stock compensation expense of $526,295 for grant of stock options to employees, directors and consultants, and a net change in operating liabilities of $126,961. Net cash flows used in operating activities for the nine months ended June 30, 2017 was $32,169 resulted due to the net loss of $34,935 and a net change in operating liabilities of $2,766.

Investing Activities:

Net cash flows used in investing activities for the nine months ended June 30, 2018 were primarily due to the purchase of web-based computer software of $41,850. We did not record any cash flows in investing activities during the nine months ended June 30, 2017.

Financing Activities

Net cash flows provided by financing activities for the nine months ended June 30, 2018 was $61,994, consisting of $20,770 in cash proceeds received from an affiliate for our working capital needs, $500 in cash proceeds received from a director to open our bank account, cash received from sale of common stock of $260, and cash received from shareholders for stock subscription of $40,464. Net cash flows provided by financing activities for the nine months ended June 30, 2017 was $0.

As a result of the above activities, we experienced a net increase in cash of $46,992 for the nine months ended June 30, 2018, and a net decrease of $32,169 for the nine months ended June 30, 2017, respectively. We expect that working capital will continue to be funded through a combination of our existing sales and further issuance of securities or obtaining financing. Our ability to continue as a going concern is still dependent on our success in obtaining additional financing from investors or from sale of our common shares.

Critical Accounting Policies and Significant Judgments and Estimates

Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements which we have prepared in accordance with U.S. generally accepted accounting principles. In preparing our financial statements, we are required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. We have identified the following accounting policies that we believe require application of management’s most subjective judgments, often requiring the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Our actual results could differ from these estimates and such differences could be material.

While our significant accounting policies are described in more details in Note 2 of our annual financial statements included in our Annual Report filed with the SEC on December 28, 2017, we believe the following accounting policies to be critical to the judgments and estimates used in the preparation of our financial statements.

JOBS Act Accounting Election

We are an “emerging growth company,” as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards, and, therefore, will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.

Fair value of Financial Instruments and Fair Value Measurements

ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

Off-Balance Sheet Arrangements

We have not engaged in any off-balance sheet arrangements as defined in Item 303(c) of the SEC’s Regulation S-B. We did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special-purpose entities that would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Recent Accounting Pronouncements

We have implemented all new accounting pronouncements that are in effect and that may impact our financial statements and do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

Item 3.

Quantitative and Qualitative Disclosures About Market Risks.

Not Applicable.

Item 4.

Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation of the effectiveness of disclosure controls and procedures as of the end of the period covered by this report under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures as of June 30, 2018 were not effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. The term “disclosure controls and procedures,” as defined under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Notwithstanding the identified material weaknesses, management believes the financial statements included in this quarterly report on Form 10-Q fairly represent in all material respects our financial condition, results of operations and cash flows at and for the periods presented in accordance with U.S. GAAP.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 under the Exchange Act that occurred during the three months ended June 30, 2018, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II.

Item 1.

Legal Proceedings.

We are not a party to any legal proceedings.

Item 1A.

Risk Factors.

Not Applicable

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

All of the securities set forth above were sold pursuant to exemptions from registration under Section 4(2) and/or Reg. S of the Securities Act of 1933, as amended, as transactions by an issuer not involving any public offering. No general advertising or solicitation was used. And the investors were purchasing the Shares for investment purposes only, without a view to resale. All issued securities were affixed with appropriate legends restricting sales and transfers.

Item 3.

Defaults Upon Senior Securities.

None

Item 4.

Mine Safety Disclosures.

None

Item 5.

Other Information.

None

Item 6.

Exhibits.

(a) Exhibits.

Exhibit		Item

31.1		Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002

31.2		Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002

32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Natural Health Farm Holdings Inc.

Date: August 14, 2018	/s/ Tee Chuen Meng
	Tee Chuen Meng, President (Principal Executive Officer and Principal Accounting Officer)

EXHIBIT INDEX

Exhibit		Item

31.1		Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002

31.2		Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002

32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

EX-31 2 ex31_1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION

I, Tee Chuen Meng, certify that:

1.	I have reviewed this report on Form 10-Q of Natural Health Farm Holdings Inc. (“Registrant”);

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.	The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

	a.	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	c.	disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

5.	The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

	a.	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

	b.	any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

	/s/ Tee Chuen Meng
	Tee Chuen Meng
	President (Principal Executive Officer)

	August 14, 2018

EX-31 3 ex31_2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION

I, Tee Chuen Meng, certify that:

1.	I have reviewed this report on Form 10-Q of Natural Health Farm Holdings Inc. (“Registrant”);

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.	The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have:

	a.	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	c.	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

5.	The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):

	a.	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

	b.	any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

	/s/ Tee Chuen Meng
	Tee Chuen Meng, Chief Financial Officer
	(Principal Accounting Officer)

	August 14, 2018

EX-32 4 ex32_1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the report of Natural Health Farm Holdings Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ Tee Chuen Meng
	Tee Chuen Meng
	President (Principal Executive Officer) and Chief Financial Officer (Principal Accounting Officer)


	August 14, 2018

EX-101.INS 5 nhel-20180630.xml XBRL INSTANCE FILE 0001621697 2017-10-01 2018-06-30 0001621697 2018-08-14 0001621697 2017-09-30 0001621697 2018-06-30 0001621697 2018-04-01 2018-06-30 0001621697 2017-04-01 2017-06-30 0001621697 2016-10-01 2017-06-30 0001621697 2016-09-30 0001621697 2017-06-30 0001621697 2016-11-29 2016-11-30 0001621697 us-gaap:FairValueInputsLevel1Member 2018-06-30 0001621697 us-gaap:FairValueInputsLevel1Member 2017-09-30 0001621697 us-gaap:FairValueInputsLevel2Member 2018-06-30 0001621697 us-gaap:FairValueInputsLevel2Member 2017-09-30 0001621697 us-gaap:FairValueInputsLevel3Member 2018-06-30 0001621697 us-gaap:FairValueInputsLevel3Member 2017-09-30 0001621697 2017-11-19 2017-11-20 0001621697 2017-12-20 2017-12-21 0001621697 2017-12-10 2017-12-11 0001621697 2017-12-27 2017-12-28 0001621697 us-gaap:DirectorMember 2018-04-01 2018-06-30 0001621697 us-gaap:DirectorMember 2017-10-01 2018-06-30 0001621697 us-gaap:DirectorMember 2018-06-30 0001621697 us-gaap:ChiefExecutiveOfficerMember 2018-04-01 2018-06-30 0001621697 us-gaap:ChiefExecutiveOfficerMember 2017-10-01 2018-06-30 0001621697 us-gaap:ChiefExecutiveOfficerMember 2018-06-30 0001621697 2016-11-30 0001621697 nhel:ConsultingAgreementsMember nhel:TwoContractorsMember 2016-11-30 0001621697 nhel:ConsultingAgreementsMember nhel:TwoContractorsMember 2016-11-29 2016-11-30 0001621697 nhel:ShareExchangeAgreementMember nhel:ShareholdersMember 2018-02-28 2018-03-01 0001621697 nhel:ShareExchangeAgreementMember nhel:ShareholdersMember 2018-03-01 0001621697 nhel:ConsultingAgreementsMember nhel:TwoContractorsMember 2018-05-15 2018-05-16 0001621697 nhel:ShareExchangeAgreementMember nhel:ShareholdersMember 2018-05-15 2018-05-16 0001621697 nhel:ShareExchangeAgreementMember nhel:ShareholdersMember 2018-06-30 0001621697 2018-05-15 2018-05-16 0001621697 nhel:ConsultingAgreementsMember nhel:BusinessAdvisoryServicesMember 2018-06-20 2018-06-21 0001621697 nhel:Plan2018Member 2018-05-30 0001621697 nhel:Plan2018Member nhel:TwoDirectorsMember 2018-05-29 2018-05-30 0001621697 nhel:Plan2018Member nhel:TwoDirectorsMember 2018-05-30 0001621697 2018-05-29 2018-05-30 0001621697 nhel:EmployeesandDirectorsMember 2018-05-29 2018-05-30 0001621697 nhel:NonemployeesMember 2018-05-29 2018-05-30 0001621697 nhel:GHSInvestmentsIncMember 2018-06-30 0001621697 nhel:GHSInvestmentsIncMember nhel:EquityFinancingAgreementAndRegistrationRightsAgreementMember 2018-06-05 0001621697 nhel:GHSInvestmentsIncMember nhel:EquityFinancingAgreementAndRegistrationRightsAgreementMember 2018-06-02 2018-06-05 0001621697 nhel:GHSInvestmentsIncMember nhel:EquityFinancingAgreementAndRegistrationRightsAgreementMember 2018-06-04 2018-06-30 0001621697 nhel:GHSInvestmentsIncMember 2017-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares nhel:Number xbrli:pure NATURAL HEALTH FARM HOLDINGS INC 0001621697 10-Q NHEL 2018-06-30 false --09-30 No No Yes Smaller Reporting Company Q3 2018 161405000

51592

34268

85860

11627

2070

4219

63924

23114

40810

53861

78067

98837

500

80137

272968

80137

272968

150150

161405

-111821

558993

-118466

-897456

-80137

-187108

85860

4600

40000

0.001

500000000

150150000

161405000

150150000

161405000

10050

152379579

156201374

150150000

-0.01

-0.00

-778990

-718885

-25790

-34935

-778990

-718885

-25790

-34935

-219

-778771

-718666

-25790

-34935

794404

726928

25790

34935

41374

33227

7240

35845 12130 6738 8643 145240 109626

15633

8262

7582

3488

23215

11750

8139 5167 15076 6583

5650

19052

105000

7582

3488

26848

-32169

2149

2070

11627

4600

-696

-41850

41850

46992

-32169

61994

500

20770

NOTE 1 – NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN   Natural Health Farm Holdings Inc. (the “Company”, “We”, “Its”, and “NHFH”) was incorporated under the laws of the State of Nevada on July 10, 2014 (Inception date). The Company has developed web-based business and launched itself into the healthcare industry. The Company has plans to provide through its subsidiaries, retail nutritional supplements, organic foods, personal care, and other health care products. The Company currently provides nutritional consulting services by offering a web based naturopathic learning management system that allows distributors, chiropractors and consumers to educate users products with the health-related aspects of various illnesses, and how the Company’s learning systems could be used to improve their general wellbeing.   On November 30, 2016, the Company filed a certificate of amendment to its articles of incorporation with the Nevada Secretary of State to change its name from Amber Group Inc. to Natural Health Farm Holdings Inc. The Company effectuated a 30:1 forward stock split of its common stock and increased its authorized share capital to 500,000,000 (Five Hundred Million) shares. This amendment was unanimously approved by the Company’s board of directors on November 29, 2016 and with the stockholders holding a majority of the Company’s voting power.   On March 16, 2017, Financial Industry Regulatory Authority (FINRA) approved the corporate name change to Natural Health Farm Holdings Inc., approved the increase in the Company’s authorized shares of common stock to 500,000,000 shares, and approved 30:1 forward stock split effective March 17, 2017, and provided us a trading symbol for our common stock as “NHEL”.   Basis of Presentation   The accompanying interim condensed financial statements are unaudited, but in the opinion of management of the Company, contain all adjustments, which include normal recurring adjustments necessary to present fairly the financial position at June 30, 2018, and the results of operations for three months and nine months ended June 30, 2018, and cash flows for the nine months ended June 30, 2018 and 2017. The balance sheet as of September 30, 2017 is derived from the Company’s audited financial statements.   Certain information and footnote disclosures normally included in financial statements that have been prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission, although management of the Company believes that the disclosures contained in these interim condensed financial statements are adequate to make the information presented therein not misleading. For further information, refer to the financial statements and the notes thereto contained in the Company’s September 30, 2017 Annual Report filed with the Securities and Exchange Commission on Form 10-K on December 28, 2017.   Going Concern   The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has generated small revenues and has sustained cumulative operating losses since July 10, 2014 (Inception Date) to date and allow it to continue as a going concern. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders and affiliates, the ability of the Company to obtain necessary financing to continue operations, and the attainment of profitable operations. The Company has recorded a net loss of $778,990 from October 1, 2017 to June 30, 2018, provided net cash flows in operating activities of $26,848, has a working capital deficit of $221,377, and has an accumulated deficit of $897,456 as of June 30, 2018. The Company has had difficulty in obtaining working capital lines of credit from financial institutions and trade credit from vendors. These factors, among others, raise a substantial doubt regarding the Company’s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

63924

260

40000

53861

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   The following summary of significant accounting policies of the Company is presented to assist in the understanding of the Company’s financial statements. The financial statements and notes are the representation of the Company’s management who is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America (“GAAP”) in all material respects and have been consistently applied in preparing the accompanying financial statements.   Use of Estimates   The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related party. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Companys estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.   Cash and Cash Equivalents   The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. The Company had a cash balance of $46,992 at June 30, 2018 and $0 at September 30, 2017, respectively.   Prepaid Expenses   Prepaid expenses represent payments made by the Company in advance for which the services have not been received. The Company recorded $4,600 and $0 in prepaid expense at June 30, 2018 and September 30, 2017, respectively.   Computer Software Costs   Computer software costs include direct costs incurred for purchase of developed software products and payments made to independent software developers. The Company accounts for computer software costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (ASC Subtopic 985-20). Computer software costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Computer software costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to computer software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered research and development that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation.   Commencing upon product release, capitalized computer software costs are amortized on the straight-line method over a thirty-six months period. The Company evaluates the future recoverability of capitalized computer software costs on an annual basis.   Revenue Recognition   The Company generates revenue from licensing and other software services from its web-based software to distributors and retailers of nutritional supplements in the healthcare industry. The Company recognize licensing fees and other software services as revenue over the period of the contract at the time that the computer software is delivered and accepted by the customer, the selling price is fixed, and collection is reasonably assured, provided no significant obligations remain. The Company considers authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting.   Deferred revenues represent billings or cash received in excess of revenue recognizable on service agreements that are not accounted for as revenues.   Concentration of Risk   Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company does not have the cash balances in excess of Federal Deposit Insurance Corporation limit at June 30, 2018 and September 30, 2017, respectively   Income Taxes   The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.   The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions.” When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying condensed balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.   Earnings (Loss) Per Common Share   The Company computes net earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted net earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. At June 30, 2018 and September 30, 2017, there were options granted to certain employees and independent consultants that when vested convert into 450,000 shares of common stock. At June 30, 2018 and September 30, 2017, there were no convertible notes, warrants available for conversion that if exercised, may dilute future earnings per share.   Fair value of Financial Instruments and Fair Value Measurements   ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:   Level 1   Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.   Level 2   Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.   Level 3   Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.   The following table presents assets and liabilities that were measured and recognized at fair value as of June 30, 2018 on a recurring basis:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; width: 54%; border-bottom: black 1pt solid; text-align: center">Description</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"></td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"></td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"></td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">None</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"></td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left">$</td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td></tr></table>   The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; width: 54%; border-bottom: black 1pt solid; text-align: center">Description</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"></td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"></td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"></td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"></td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">None</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"></td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left">$</td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left">$</td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td></tr></table>   Recent Accounting Pronouncements   In June 2016, the FASB issued Accounting Standards Update (ASU) 2016-13, Financial Instruments - Credit Losses (Topic 326) The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. This ASU is effective for financial statements issued for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements.  In 2015, the FASB issued ASU No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes, which requires all deferred tax assets and liabilities to be classified as noncurrent in a classified balance sheet. Current US GAAP requires an entity to separate deferred tax assets and liabilities into current and noncurrent amounts in a classified balance sheet. For public entities, ASU 2015-17 is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, ASU 2015-17 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018, and may be applied either prospectively or retrospectively, with early application permitted for financial statements that have not been previously issued. The Company has not yet determined the effect of the adoption of this standard on the Company’s financial position and results of operations.

NOTE 3 – PREPAID EXPENSE   The Company recorded prepaid expense of $4,600 and $0 at June 30, 2018 and September 30, 2017. Prepaid expense consisted of $4,000 relating to legal fees and $600 for stock transfer agent fees, paid in advance as of June 30, 2018. No prepayments of expenses were made as of September 30, 2017.

NOTE 4 – COMPUTER SOFTWARE COSTS   The Company purchased web-based naturopathic learning management system computer software, developed by a third party, to educate users with the health-related products for various illnesses, and how the Company’s learning systems could be used to improve their general wellbeing. The amount capitalized include direct costs incurred in developing the software purchased from the third party.   The following table presents details of our computer software costs as of June 30, 2018 and September 30, 2017:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center; font-family: Times New Roman, Times, Serif">Balance at September 30, 2017</td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Additions</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Amortization</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center; font-family: Times New Roman, Times, Serif">Balance at June 30, 2018</td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 2.5pt; text-align: left">Computer Software Costs, net</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: black 2.5pt double; text-align: left">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: black 2.5pt double; text-align: left">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right">41,850</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: black 2.5pt double; text-align: left">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right">(7,582</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: black 2.5pt double; text-align: left">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right">34,268</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>     Computer software costs are being amortized on a straight-line basis over their estimated life of three years.   Amortization expense for computer software costs was $3,488 and $0 for the three months ended June 30, 2018 and 2017, and $7,582 and $0 for the nine months ended June 30, 2018 and 2017, respectively.   The estimated future amortization expense of computer software costs as of June 30, 2018 is as follows:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: black 1pt solid; font-weight: bold">Year ending September 30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-size: 10pt; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; width: 84%; text-align: left">2018</td> <td style="font-size: 10pt; width: 1%; text-align: left"> </td> <td style="font-size: 10pt; width: 1%"> </td> <td style="font-size: 10pt; width: 1%; text-align: left">$</td> <td style="font-size: 10pt; width: 12%; text-align: right">3,488</td> <td style="font-size: 10pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="font-size: 10pt; text-align: left">2019</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">13,950</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2020</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">13,950</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="font-size: 10pt; text-align: left">2021</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">2,880</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="font-size: 10pt; border-bottom: black 2.5pt double; text-align: left">$</td> <td style="font-size: 10pt; border-bottom: black 2.5pt double; text-align: right">34,268</td></tr></table>

NOTE 5 – ACCOUNTS PAYABLE   Accounts payable at June 30, 2018 and September 30, 2017 totaled $11,627 and $0, respectively. Accounts payable consisted of $11,627 and $0 in legal and consulting fees payable as of June 30, 2018 and September 30, 2017, respectively.

NOTE 6 – PAYABLE TO AFFILIATES   The Company has received an advance of $500 from a director for its working capital needs as of June 30, 2018 (see NOTE 7).   The Company has received advances from an affiliate for its working capital needs from an entity in which its Chief Executive Officer is also a director in such entity (NOTE 6). The advance received is non-interest bearing, unsecured and payable on demand is summarized as follows. <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center; font-family: Times New Roman, Times, Serif">Balance June 30, 2018</td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center; font-family: Times New Roman, Times, Serif">Balance September 30,2017</td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 72%; padding-bottom: 1pt; text-align: left">Payable to affiliate</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left">$</td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right">98,837</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: left"> </td> <td style="width: 1%; border-bottom: black 1pt solid; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left">$</td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right">78,067</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">98,837</td> <td style="border-bottom: black 2.5pt double; text-align: left"> </td> <td style="border-bottom: black 2.5pt double"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">78,067</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

NOTE 7 – RELATED PARTY TRANSACTIONS   The Company received an advance of $500 and $0 from a director for its working capital needs as of June 30, 2018 and September 30, 2017, respectively. Funds advanced to the Company by the director are non-interest bearing, unsecured and due on demand (NOTE 6).   The Company has received advances for its working capital needs from an affiliate in which the Company’s Chief Executive Officer holds the position of director in such entity (see NOTE 6).   On November 20, 2017, the Company sold ten (10) naturopathic learning management system and modules for $29,000 to an entity solely owned by a director of the Company. The Company received the payment in full of $29,000 on December 21, 2017. The Company recorded $2,417 and $5,886 as revenues earned for the three months and nine months ended June 30, 2018, and $23,114 as deferred revenues at June 30, 2018.   On December 11, 2017, the Company sold twenty (20) naturopathic learning management systems and modules for $50,000 to an entity in which the Company Chief Executive Officer holds the position of director in such entity. The Company received the payment of $50,000 on December 28, 2017. The Company recorded $4,167 and $9,190 as revenues earned for the three months and nine months ended June 30, 2018 and $40,810 as deferred revenues at June 30, 2018.   On May 30, 2018, the Company granted stock options to three officers/directors to purchase 250,000 shares of common stock at exercise price of $1.50 per share over a five (5) years term.

NOTE 9 – COMMITMENTS AND CONTINGENCIES   Litigation Costs and Contingencies   From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Other than as set forth below, management is currently not aware of any such legal proceedings or claims that could have, individually or in the aggregate, a material adverse effect on our business, financial condition, or operating results.   In the normal course of business, the Company incurs costs to hire and retain external legal counsel to advise it on regulatory, litigation and other matters. The Company expenses these costs as the related services are received. If a loss is considered probable and the amount can be reasonable estimated, the Company recognizes an expense for the estimated loss.

NOTE 10: STOCKHOLDERS’ DEFICIT   The Company’s capitalization at June 30, 2018 was 500,000,000 authorized common shares with a par value of $0.001 per share.   Common Stock   On November 30, 2016, the Company increased the authorized share capital from 75,000,000 shares of common stock to 500,000,000 shares of common stock. In addition, the Company effectuated a 30:1 forward stock split of the common stock on such date.   On February 1, 2018, the Company entered into consulting agreements with two contractors for providing business advisory and consulting services. The Company issued 1,000,000 shares of common stock valued at $20,000 as the fair market value of the stock.   On March 1, 2018, the Company entered into a Share Exchange Agreement (the “Agreement”) with its shareholders whereby, the shareholders agreed to exchange, sell, convey, transfer and assign to the Company their shareholdings, free and clear of all liens, pledges, encumbrances, changes, restrictions or known claims of any kind, nature or description plus pay to the Company an aggregate purchase price of $50 (the “Purchase Price”), and the Company agreed to accept from its shareholders the old shares plus the Purchase Price in exchange for the transfer of old shares the new shares. As of June 30, 2018, the Company received cash proceeds of $40,464 from its shareholders to exchange the old shares for new shares and recorded it as contributed capital in the accompanying financial statements.   On May 16, 2018, the Company issued 50,000 shares of its common stock for a cash consideration of $50 pursuant to an agreement dated February 15, 2018. In addition, on the same date, the Company issued 105,000 shares of common stock for a cash consideration of $210 pursuant to an agreement dated March 1, 2018. The common shares issued were valued at the fair value on the date of execution of the agreement to issue such shares.   On May 16, 2018, the Company issued 10,050,000 shares of common stock for a cash consideration of $10,050 pursuant to an agreement dated March 1, 2018. The common shares were valued at $10,050 being their fair value on the date of execution of the agreement. The Company recorded $10,050 as subscriptions receivable as of June 30, 2018 since the Company did not receive the cash proceeds for stock subscriptions.   On June 21, 2018, the Company issued 50,000 shares of common stock to a consultant pursuant to an agreement, for providing consulting and business advisory services to the Company. The common shares were valued at $85,000 being their fair value on the date of execution of the agreement to issue such shares.   As a result of all common stock issuances, the Company had 161,405,000 shares and 150,150,000 shares of common stock issued and outstanding at June 30, 2018 and September 30, 2017, respectively.   Stock Option Plan   On May 30, 2018, the Board of Directors authorized and approved the 2018 Non-Qualified Stock Option Plan (the â2018 Plan) and reserved 10,000,000 shares of the Companys common stock intended to be issued to selected officers, directors, consultants and key employees provided that bona fide services shall be rendered by such consultants or advisors and such services must not be in connection with the offer or sale of securities in a capital-raising transaction and do not promote or maintain a market for the Companys securities. The Company filed a Registration Statement with the SEC on May 31, 2018 disclosing formation of 2018 Plan.   On May 30, 2018, the Board granted stock options under the 2018 Plan to two directors, an officer and an employee, and three independent consultants to purchase up to 450,000 shares of common stock with a five-year term. The stock options vested immediately upon the issuance date. The exercise price of the stock options to purchase common stock was at $1.50 per share, and the quoted market price of the Company stock on the grant date was $1.70. The option to purchase common stock expires on May 30, 2023. The fair value of options granted was $526,295, calculated using Black-Scholes option pricing model using the assumptions of risk free discount rate of 2.79%, volatility of 106%, 2.5 year-term for employees and directors and 5 year-term for non-employees, and dividend yield of 0%. The Company has recorded stock compensation expense of $526,295 for the three months and nine months ended June 30, 2018.

NOTE 11 – SUBSEQUENT EVENTS    Management has evaluated subsequent events through August 14, 2018, the date the financial statements were available to be issued, noting no new transactions that would require additional disclosure.

Use of Estimates   The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related party. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Cash and Cash Equivalents   The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. The Company had a cash balance of $46,992 at June 30, 2018 and $0 at September 30, 2017, respectively.

Prepaid Expenses   Prepaid expenses represent payments made by the Company in advance for which the services have not been received. The Company recorded $4,600 and $0 in prepaid expense at June 30, 2018 and September 30, 2017, respectively.

Computer Software Costs   Computer software costs include direct costs incurred for purchase of developed software products and payments made to independent software developers. The Company accounts for computer software costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Computer software costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Computer software costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to computer software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation.   Commencing upon product release, capitalized computer software costs are amortized on the straight-line method over a thirty-six months period. The Company evaluates the future recoverability of capitalized computer software costs on an annual basis.

Revenue Recognition   The Company generates revenue from licensing and other software services from its web-based software to distributors and retailers of nutritional supplements in the healthcare industry. The Company recognize licensing fees and other software services as revenue over the period of the contract at the time that the computer software is delivered and accepted by the customer, the selling price is fixed, and collection is reasonably assured, provided no significant obligations remain. The Company considers authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting.   Deferred revenues represent billings or cash received in excess of revenue recognizable on service agreements that are not accounted for as revenues.

Concentration of Risk   Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company does not have the cash balances in excess of Federal Deposit Insurance Corporation limit at June 30, 2018 and September 30, 2017, respectively.

Income Taxes   The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.   The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions.” When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying condensed balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

Earnings (Loss) Per Common Share   The Company computes net earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted net earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. At June 30, 2018 and September 30, 2017, there were options granted to certain employees and independent consultants that when vested convert into 450,000 shares of common stock. At June 30, 2018 and September 30, 2017, there were no convertible notes, warrants available for conversion that if exercised, may dilute future earnings per share.

Fair value of Financial Instruments and Fair Value Measurements   ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:   Level 1   Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.   Level 2   Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.   Level 3   Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.   The Companys financial instruments consist principally of cash, accounts payable, accrued expenses and payable to an affiliate. Pursuant to ASC 820, Fair Value Measurements and Disclosures and ASC 825, Financial Instrument, the fair value of our cash equivalents is determined based on Level 1 inputs, which consist of quoted prices in active markets for identical assets. The Company believes that the recorded values of all the other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.   The following table presents assets and liabilities that were measured and recognized at fair value as of June 30, 2018 on a recurring basis:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; width: 54%; border-bottom: black 1pt solid; text-align: center">Description</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">None</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left">$</td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left">$</td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left">$</td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td></tr></table>   The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; width: 54%; border-bottom: black 1pt solid; text-align: center">Description</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="font-size: 10pt; width: 12%; border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="font-size: 10pt; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">None</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left">$</td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left">$</td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td> <td style="font-size: 10pt; padding-bottom: 1pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: left">$</td> <td style="font-size: 10pt; border-bottom: black 1pt solid; text-align: right">-</td></tr></table>

Recent Accounting Pronouncements   In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses (Topic 326).” The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. This ASU is effective for financial statements issued for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements.   In 2015, the FASB issued ASU No. 2015-17, “Income Taxes” (Topic 740): Balance Sheet Classification of Deferred Taxes, which requires all deferred tax assets and liabilities to be classified as noncurrent in a classified balance sheet. Current US GAAP requires an entity to separate deferred tax assets and liabilities into current and noncurrent amounts in a classified balance sheet. For public entities, ASU 2015-17 is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, ASU 2015-17 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018, and may be applied either prospectively or retrospectively, with early application permitted for financial statements that have not been previously issued. The Company has not yet determined the effect of the adoption of this standard on the Company’s financial position and results of operations.

The following table presents assets and liabilities that were measured and recognized at fair value as of June 30, 2018 on a recurring basis:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td style="width: 54%; border-bottom: black 1pt solid; text-align: center">Description</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">None</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>   The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td style="width: 54%; border-bottom: black 1pt solid; text-align: center">Description</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left"> </td> <td style="width: 12%; border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">None</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left">$</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

The following table presents details of our computer software costs as of June 30, 2018 and September 30, 2017:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center; font-family: Times New Roman, Times, Serif">Balance at September 30, 2017</td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Additions</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Amortization</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center; font-family: Times New Roman, Times, Serif">Balance at June 30, 2018</td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 2.5pt; text-align: left">Computer Software Costs, net</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: black 2.5pt double; text-align: left">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: black 2.5pt double; text-align: left">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right">41,850</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: black 2.5pt double; text-align: left">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right">(7,582</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; border-bottom: black 2.5pt double; text-align: left">$</td> <td style="width: 12%; border-bottom: black 2.5pt double; text-align: right">34,268</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

The estimated future amortization expense of computer software costs as of June 30, 2018 is as follows:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font-weight: bold">Year ending September 30,</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center">Amount</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 85%; text-align: left">2018</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">3,488</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">2019</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">13,950</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2020</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">13,950</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">2021</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">2,880</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">34,268</td></tr> </table>

The advance received is non-interest bearing, unsecured and payable on demand is summarized as follows.   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center; font-family: Times New Roman, Times, Serif">Balance June 30, 2018</td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center; font-family: Times New Roman, Times, Serif">Balance September 30,2017</td> <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 72%; padding-bottom: 1pt; text-align: left">Payable to affiliate</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left">$</td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right">98,837</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: left"> </td> <td style="width: 1%; border-bottom: black 1pt solid; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left">$</td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right">78,067</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">98,837</td> <td style="border-bottom: black 2.5pt double; text-align: left"> </td> <td style="border-bottom: black 2.5pt double"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">78,067</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

NOTE 8 – EQUITY FINANCING AGREEMENT AND NOTE PAYABLE   Note payable consist of:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; font-weight: bold; text-align: center">June 30, 2018</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; font-weight: bold; text-align: center">September 30, 2017</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 72%; padding-bottom: 1pt; text-align: left">Note payable - GHS Investments, Inc.</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left">$</td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right">40,000</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: left">$</td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right">-</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Total</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">40,000</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: left">Current portion</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">40,000</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   On June 5, 2018, the Company entered into an Equity Financing Agreement and Registration Rights Agreement with GHS Investments Inc. (“GHS”) pursuant to which GHS agreed to purchase up to $20,000,000 in shares of Company common stock. The obligations of GHS to purchase the shares of Company common stock are subject to the conditions set forth in the Equity Financing Agreement, including, without limitation, the condition that a registration statement on Form S-1 registering the shares of Company common stock to be sold to GHS be filed with the Securities and Exchange Commission and become effective. The Registration Rights Agreement provides that the Company shall use commercially reasonable efforts to file the registration statement within 30 days after the date of the Registration Rights Agreement and have the registration statement become effective within 90 days after it is filed. In connection with the Equity Financing Agreement, the Company executed a promissory note in the principal amount of $40,000 (the “Note”) as payment of the commitment fee for the Equity Financing Agreement. The Note bears interest at the rate of 8% and must be repaid on or before March 5, 2019. The Company has recorded the commitment fee as an expense in the accompanying statements of operations for the nine months ended June 30, 2018. The Company has accrued the interest expense of $219 on the principal balance of $40,000 for the period from June 5, 2018 to June 30, 2018. 10050 40464

526295

30:1 forward stock split

221377

P3Y

4600

450000

4000 600

41850

3488 13950 13950 2880 11627

78067

98837

500

10 20

29000

50000

2417

5886

4167

9190

75000000

1000000

105000

50000

20000

85000

10050

40464

210

10050

50000

10050000

10000000

450000

P5Y

1.5

1.70

2023-05-30

526295

0.0279

1.06

0.00

20000000

40000

0.08

219

2019-05-23

P2Y6M

P5Y

40000

EX-101.SCH 6 nhel-20180630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - SUMMARY OF SIGNIFCANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - PREPAID EXPENSE link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - COMPUTER SOFTWARE COSTS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - ACCOUNTS PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - PAYABLE TO AFFILIATES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - EQUITY FINANCING AGREEMENT AND NOTE PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - COMPUTER SOFTWARE COSTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - PAYABLE TO AFFILIATES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - PREPAID EXPENSE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - COMPUTER SOFTWARE COSTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - COMPUTER SOFTWARE COSTS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - COMPUTER SOFTWARE COSTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - ACCOUNTS PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - PAYABLE TO AFFILIATES (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - PAYABLE TO AFFILIATES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - STOCKHOLDERS' DEFICIT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - STOCKHOLDERS' DEFICIT (Details Narrative 1) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - EQUITY FINANCING AGREEMENT AND NOTE PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - EQUITY FINANCING AGREEMENT AND NOTE PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 nhel-20180630_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 nhel-20180630_def.xml XBRL DEFINITION FILE EX-101.LAB 9 nhel-20180630_lab.xml XBRL LABEL FILE Fair Value, Hierarchy [Axis] Level 1 [Member] Level 2 [Member] Level 3 [Member] Related Party [Axis] Director [Member] Chief Executive Officer [Member] Type of Arrangement [Axis] Consulting Agreements [Member] Two Contractors [Member] Share Exchange Agreement [Member] Shareholders [Member] Business Advisory Services [Member] Plan Name [Axis] 2018 Plan [Member] Title of Individual [Axis] Two directors [Member] Employees and Directors [Member] Non-employees [Member] Debt Instrument [Axis] GHS Investments, Inc [Member] Equity Financing Agreement and Registration Rights Agreement [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Trading Symbol Document Period End Date Amendment Flag Current Fiscal Year End Date Entity a Well-known Seasoned Issuer Entity a Voluntary Filer Entity's Reporting Status Current Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Prepaid expense Total Current Assets Computer Software, net Total Assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable Accrued expense Deferred revenue - related party Deferred revenue - third party Payable to affiliate Note payable Advance from director Total Current Liabilities Total Liabilities Stockholders' Deficit Common Stock, $0.001 par value, 500,000,000 shares authorized, 161,405,000 shares and 150,150,000 shares issued and outstanding at June 30, 2018 and September 30, 2017, respectively Additional Paid in Capital Stock subscriptions receivable Accumulated Deficit Total Stockholders' Deficit Total Liabilities and Stockholders' Deficit Common stock, par value (in dollars per share) Common stock, authorized Common stock, issued Common stock, outstanding Income Statement [Abstract] Revenues - related party Revenues - non-related party Total Revenues Cost of Goods Sold Gross Profit Operating Expenses: Consulting fees Legal and filing fees Professional fees Loan commitment fee Stock compensation Other general and administrative Total Operating Expenses Loss from Operations Other Income (Expense) Loss Before Provision For Income Tax Provision for Income Tax Net Loss Basic and Dilutive Net Loss Per Share (in dollars per share) Weighted Average Number of Shares Outstanding - Basic and Diluted (in shares) Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Net Loss Adjustment to reconcile net loss to net cash provided by (used in) operating activities Amortization of computer software costs Common stock issued to consultants for services Stock compensation expense upon grant of stock options Changes in operating assets and liabilities (Increase) decrease in prepaid expense Increase in accounts payable Increase in accrued expense Increase in deferred revenue - related party Increase in deferred revenue - third party Net Cash Flows Provided by (Used in) Operating Activities Cash Flows from Investing Activities Purchase of computer software Net Cash Flows Used in Investing Activities Cash Flows from Financing Activities Cash proceeds from affiliate Cash advance from director Cash proceeds from sale of common shares Cash proceeds from stock subscriptions Net Cash Flows Provided by Financing Activities Net Increase in Cash and Cash Equivalents Cash and Cash Equivalents, Beginning of the Period Cash and Cash Equivalents, End of the Period Supplemental Disclosures of Cash Flow Information: Cash paid for Income Taxes Cash paid for Interest Supplemental disclosures of non-cash investing and financing activities: Stock issued for subscriptions receivable Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Prepaid Expense and Other Assets [Abstract] PREPAID EXPENSE Goodwill and Intangible Assets Disclosure [Abstract] COMPUTER SOFTWARE COSTS Payables and Accruals [Abstract] ACCOUNTS PAYABLE Payable To Affiliates PAYABLE TO AFFILIATE Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Debt Disclosure [Abstract] EQUITY FINANCING AGREEMENT AND NOTE PAYABLE Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] STOCKHOLDERS' DEFICIT Subsequent Events [Abstract] SUBSEQUENT EVENTS Use of Estimates Cash and Cash Equivalents Prepaid Expenses Computer Software Costs Revenue Recognition Concentration of Risk Income Taxes Earnings (Loss) Per Common Share Fair value of Financial Instruments and Fair Value Measurements Recent Accounting Pronouncements Schedule of assets and liabilities measured and recognized at fair value Schedule of computer software costs Schedule of estimated future amortization expense of computer software costs Schedule of payable to affiliate Description of forward stock split Increased authorized share capital Net loss Accumulated deficit Net cash used in operating activities Working capital deficit Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Hierarchy and NAV [Axis] Assets and liabilities at fair value Cash balance Useful life of computer software Prepaid expense Number of vested shares Expense related to legal fees Stock transfer agent fees Balance at beginning Additions Amortization Balance at end 2018 2019 2020 2021 Total Accounts payable consist legal and consulting fees payable Total Advance from director Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Number of naturopathic learning management system sold Proceeds from naturopathic learning management system sold Revenue from related parties Deferred revenue from related parties Number of shares granted Statement [Table] Statement [Line Items] Type of Arrangement and Non-arrangement Transactions [Axis] Previously common stock, authorized Value of shares issued Number of shares issued, value Purchase price (in dollars per share) Cash proceeds from issuance of shares EX-101.PRE 10 nhel-20180630_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Jun. 30, 2018	Aug. 14, 2018
Document And Entity Information
Entity Registrant Name	NATURAL HEALTH FARM HOLDINGS INC
Entity Central Index Key	0001621697
Document Type	10-Q
Trading Symbol	NHEL
Document Period End Date	Jun. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Entity a Well-known Seasoned Issuer	No
Entity a Voluntary Filer	No
Entity's Reporting Status Current	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		161,405,000
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2018

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS (Unaudited) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Current Assets
Cash and cash equivalents	$ 46,992
Prepaid expense	4,600
Total Current Assets	51,592
Computer Software, net	34,268
Total Assets	85,860	0
Current Liabilities
Accounts payable	11,627
Accrued expense	4,219	2,070
Deferred revenue - related party	63,924
Deferred revenue - third party	53,861
Payable to affiliate	98,837	78,067
Note payable	40,000
Advance from director	500
Total Current Liabilities	272,968	80,137
Total Liabilities	272,968	80,137
Stockholders' Deficit
Common Stock, $0.001 par value, 500,000,000 shares authorized, 161,405,000 shares and 150,150,000 shares issued and outstanding at June 30, 2018 and September 30, 2017, respectively	161,405	150,150
Additional Paid in Capital	558,993	(111,821)
Stock subscriptions receivable	(10,050)
Accumulated Deficit	(897,456)	(118,466)
Total Stockholders' Deficit	(187,108)	(80,137)
Total Liabilities and Stockholders' Deficit	$ 85,860	$ 0

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2018	Sep. 30, 2017
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized	500,000,000	500,000,000
Common stock, issued	161,405,000	150,150,000
Common stock, outstanding	161,405,000	150,150,000

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Revenues - related party	$ 6,583		$ 15,076
Revenues - non-related party	5,167		8,139
Total Revenues	11,750		23,215
Cost of Goods Sold	3,488		7,582
Gross Profit	8,262		15,633
Operating Expenses:
Consulting fees	109,626		145,240
Legal and filing fees	12,130	6,738	35,845	8,643
Professional fees	5,650	19,052	5,650	19,052
Loan commitment fee	40,000		40,000
Stock compensation	526,295		526,295
Other general and administrative	33,227		41,374	7,240
Total Operating Expenses	726,928	25,790	794,404	34,935
Loss from Operations	(718,666)	(25,790)	(778,771)	(34,935)
Other Income (Expense)	(219)		(219)
Loss Before Provision For Income Tax	(718,885)	(25,790)	(778,990)	(34,935)
Provision for Income Tax
Net Loss	$ (718,885)	$ (25,790)	$ (778,990)	$ (34,935)
Basic and Dilutive Net Loss Per Share (in dollars per share)	$ (0.00)	$ (0.00)	$ (0.01)	$ (0.00)
Weighted Average Number of Shares Outstanding - Basic and Diluted (in shares)	156,201,374	150,150,000	152,379,579	150,150,000

XML 15 R5.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash Flows from Operating Activities:
Net Loss	$ (778,990)	$ (34,935)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities
Amortization of computer software costs	7,582
Loan commitment fee	40,000
Common stock issued to consultants for services	105,000
Stock compensation expense upon grant of stock options	526,295
Changes in operating assets and liabilities
(Increase) decrease in prepaid expense	(4,600)	696
Increase in accounts payable	11,627
Increase in accrued expense	2,149	2,070
Increase in deferred revenue - related party	63,924
Increase in deferred revenue - third party	53,861
Net Cash Flows Provided by (Used in) Operating Activities	26,848	(32,169)
Cash Flows from Investing Activities
Purchase of computer software	(41,850)
Net Cash Flows Used in Investing Activities	(41,850)
Cash Flows from Financing Activities
Cash proceeds from affiliate	20,770
Cash advance from director	500
Cash proceeds from sale of common shares	260
Cash proceeds from stock subscriptions	40,464
Net Cash Flows Provided by Financing Activities	61,994
Net Increase in Cash and Cash Equivalents	46,992	(32,169)
Cash and Cash Equivalents, Beginning of the Period
Cash and Cash Equivalents, End of the Period	46,992
Supplemental Disclosures of Cash Flow Information:
Cash paid for Income Taxes
Cash paid for Interest
Supplemental disclosures of non-cash investing and financing activities:
Stock issued for subscriptions receivable	$ 10,050

XML 16 R6.htm IDEA: XBRL DOCUMENT

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN

9 Months Ended

Jun. 30, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN

NOTE 1 – NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN

Basis of Presentation

Going Concern

XML 17 R7.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFCANT ACCOUNTING POLICIES

9 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related party. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Companys estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Cash and Cash Equivalents

Prepaid Expenses

Computer Software Costs

Computer software costs include direct costs incurred for purchase of developed software products and payments made to independent software developers. The Company accounts for computer software costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (ASC Subtopic 985-20). Computer software costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Computer software costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to computer software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered research and development that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation.

Revenue Recognition

Deferred revenues represent billings or cash received in excess of revenue recognizable on service agreements that are not accounted for as revenues.

Concentration of Risk

Income Taxes

Earnings (Loss) Per Common Share

Fair value of Financial Instruments and Fair Value Measurements

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The following table presents assets and liabilities that were measured and recognized at fair value as of June 30, 2018 on a recurring basis:

Description

Level 1

Level 2

Level 3

None

The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:

Description

Level 1

Level 2

Level 3

None

Recent Accounting Pronouncements

In June 2016, the FASB issued Accounting Standards Update (ASU) 2016-13, Financial Instruments - Credit Losses (Topic 326) The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. This ASU is effective for financial statements issued for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements.

In 2015, the FASB issued ASU No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes, which requires all deferred tax assets and liabilities to be classified as noncurrent in a classified balance sheet. Current US GAAP requires an entity to separate deferred tax assets and liabilities into current and noncurrent amounts in a classified balance sheet. For public entities, ASU 2015-17 is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, ASU 2015-17 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018, and may be applied either prospectively or retrospectively, with early application permitted for financial statements that have not been previously issued. The Company has not yet determined the effect of the adoption of this standard on the Company’s financial position and results of operations.

XML 18 R8.htm IDEA: XBRL DOCUMENT

PREPAID EXPENSE

9 Months Ended

Jun. 30, 2018

Prepaid Expense and Other Assets [Abstract]

PREPAID EXPENSE

NOTE 3 – PREPAID EXPENSE

XML 19 R9.htm IDEA: XBRL DOCUMENT

COMPUTER SOFTWARE COSTS

9 Months Ended

Jun. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

COMPUTER SOFTWARE COSTS

NOTE 4 – COMPUTER SOFTWARE COSTS

The following table presents details of our computer software costs as of June 30, 2018 and September 30, 2017:

Balance at

September 30, 2017

Additions

Amortization

Balance at

June 30, 2018

Computer Software Costs, net

41,850

(7,582

)

34,268

Computer software costs are being amortized on a straight-line basis over their estimated life of three years.

Amortization expense for computer software costs was $3,488 and $0 for the three months ended June 30, 2018 and 2017, and $7,582 and $0 for the nine months ended June 30, 2018 and 2017, respectively.

The estimated future amortization expense of computer software costs as of June 30, 2018 is as follows:

Year ending September 30,	Amount
2018	$	3,488
2019		13,950
2020		13,950
2021		2,880
Total	$	34,268

XML 20 R10.htm IDEA: XBRL DOCUMENT

ACCOUNTS PAYABLE

9 Months Ended

Jun. 30, 2018

Payables and Accruals [Abstract]

ACCOUNTS PAYABLE

NOTE 5 – ACCOUNTS PAYABLE

XML 21 R11.htm IDEA: XBRL DOCUMENT

PAYABLE TO AFFILIATES

9 Months Ended

Jun. 30, 2018

Payable To Affiliates

PAYABLE TO AFFILIATE

NOTE 6 – PAYABLE TO AFFILIATES

The Company has received an advance of $500 from a director for its working capital needs as of June 30, 2018 (see NOTE 7).

	Balance June 30, 2018		Balance September 30,2017
		(Unaudited)
Payable to affiliate	$	98,837	$	78,067
Total	$	98,837	$	78,067

XML 22 R12.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS

9 Months Ended

Jun. 30, 2018

RELATED PARTY TRANSACTIONS

NOTE 7 – RELATED PARTY TRANSACTIONS

The Company has received advances for its working capital needs from an affiliate in which the Company’s Chief Executive Officer holds the position of director in such entity (see NOTE 6).

On May 30, 2018, the Company granted stock options to three officers/directors to purchase 250,000 shares of common stock at exercise price of $1.50 per share over a five (5) years term.

XML 23 R13.htm IDEA: XBRL DOCUMENT

EQUITY FINANCING AGREEMENT AND NOTE PAYABLE

9 Months Ended

Jun. 30, 2018

Debt Disclosure [Abstract]

EQUITY FINANCING AGREEMENT AND NOTE PAYABLE

NOTE 8 – EQUITY FINANCING AGREEMENT AND NOTE PAYABLE

Note payable consist of:

	June 30, 2018		September 30, 2017
		(Unaudited)
Note payable - GHS Investments, Inc.	$	40,000	$	-
Total		40,000		-

Current portion	$	40,000	$	-

XML 24 R14.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Jun. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 9 – COMMITMENTS AND CONTINGENCIES

Litigation Costs and Contingencies

XML 25 R15.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' DEFICIT

9 Months Ended

Jun. 30, 2018

Equity [Abstract]

STOCKHOLDERS' DEFICIT

NOTE 10: STOCKHOLDERS’ DEFICIT

The Company’s capitalization at June 30, 2018 was 500,000,000 authorized common shares with a par value of $0.001 per share.

Common Stock

As a result of all common stock issuances, the Company had 161,405,000 shares and 150,150,000 shares of common stock issued and outstanding at June 30, 2018 and September 30, 2017, respectively.

Stock Option Plan

On May 30, 2018, the Board of Directors authorized and approved the 2018 Non-Qualified Stock Option Plan (the â€œ2018 Plan) and reserved 10,000,000 shares of the Companys common stock intended to be issued to selected officers, directors, consultants and key employees provided that bona fide services shall be rendered by such consultants or advisors and such services must not be in connection with the offer or sale of securities in a capital-raising transaction and do not promote or maintain a market for the Companys securities. The Company filed a Registration Statement with the SEC on May 31, 2018 disclosing formation of 2018 Plan.

XML 26 R16.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS

9 Months Ended

Jun. 30, 2018

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 11 – SUBSEQUENT EVENTS

Management has evaluated subsequent events through August 14, 2018, the date the financial statements were available to be issued, noting no new transactions that would require additional disclosure.

XML 27 R17.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

Cash and Cash Equivalents

Cash and Cash Equivalents

Prepaid Expenses

Prepaid Expenses

Computer Software Costs

Computer Software Costs

Revenue Recognition

Revenue Recognition

Deferred revenues represent billings or cash received in excess of revenue recognizable on service agreements that are not accounted for as revenues.

Concentration of Risk

Concentration of Risk

Income Taxes

Income Taxes

Earnings (Loss) Per Common Share

Earnings (Loss) Per Common Share

Fair value of Financial Instruments and Fair Value Measurements

Fair value of Financial Instruments and Fair Value Measurements

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Companys financial instruments consist principally of cash, accounts payable, accrued expenses and payable to an affiliate. Pursuant to ASC 820, Fair Value Measurements and Disclosures and ASC 825, Financial Instrument, the fair value of our cash equivalents is determined based on Level 1 inputs, which consist of quoted prices in active markets for identical assets. The Company believes that the recorded values of all the other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

The following table presents assets and liabilities that were measured and recognized at fair value as of June 30, 2018 on a recurring basis:

Description

Level 1

Level 2

Level 3

None

The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:

Description

Level 1

Level 2

Level 3

None

Recent Accounting Pronouncements

Recent Accounting Pronouncements

XML 28 R18.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Schedule of assets and liabilities measured and recognized at fair value

The following table presents assets and liabilities that were measured and recognized at fair value as of June 30, 2018 on a recurring basis:

Description

Level 1

Level 2

Level 3

None

The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis:

Description

Level 1

Level 2

Level 3

None

XML 29 R19.htm IDEA: XBRL DOCUMENT

COMPUTER SOFTWARE COSTS (Tables)

9 Months Ended

Jun. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of computer software costs

The following table presents details of our computer software costs as of June 30, 2018 and September 30, 2017:

Balance at

September 30, 2017

Additions

Amortization

Balance at

June 30, 2018

Computer Software Costs, net

41,850

(7,582

)

34,268

Schedule of estimated future amortization expense of computer software costs

The estimated future amortization expense of computer software costs as of June 30, 2018 is as follows:

Year ending September 30,	Amount
2018	$	3,488
2019		13,950
2020		13,950
2021		2,880
Total	$	34,268

XML 30 R20.htm IDEA: XBRL DOCUMENT

PAYABLE TO AFFILIATES (Tables)

9 Months Ended

Jun. 30, 2018

Payable To Affiliates

Schedule of payable to affiliate

The advance received is non-interest bearing, unsecured and payable on demand is summarized as follows.

	Balance June 30, 2018		Balance September 30,2017
		(Unaudited)
Payable to affiliate	$	98,837	$	78,067
Total	$	98,837	$	78,067

XML 31 R21.htm IDEA: XBRL DOCUMENT

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN (Details Narrative) - USD ($)		3 Months Ended		9 Months Ended
	Nov. 30, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of forward stock split	30:1 forward stock split
Increased authorized share capital		500,000,000		500,000,000		500,000,000
Net loss		$ (718,885)	$ (25,790)	$ (778,990)	$ (34,935)
Accumulated deficit		(897,456)		(897,456)		$ (118,466)
Net cash used in operating activities				26,848	$ (32,169)
Working capital deficit		$ 221,377		$ 221,377

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 32 R22.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets and liabilities at fair value
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets and liabilities at fair value
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets and liabilities at fair value

XML 33 R23.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	9 Months Ended
	Jun. 30, 2018	Sep. 30, 2017	Jun. 30, 2017	Sep. 30, 2016
Accounting Policies [Abstract]
Cash balance	$ 46,992
Useful life of computer software	3 years
Prepaid expense	$ 4,600
Number of vested shares	450,000

XML 34 R24.htm IDEA: XBRL DOCUMENT

PREPAID EXPENSE (Details Narrative) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Prepaid Expense and Other Assets [Abstract]
Prepaid expense	$ 4,600
Expense related to legal fees	4,000
Stock transfer agent fees	$ 600

XML 35 R25.htm IDEA: XBRL DOCUMENT

COMPUTER SOFTWARE COSTS (Details) - USD ($)	3 Months Ended		9 Months Ended
COMPUTER SOFTWARE COSTS (Details) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Balance at beginning
Additions			41,850
Amortization	$ (3,488)		(7,582)
Balance at end	$ 34,268		$ 34,268

XML 36 R26.htm IDEA: XBRL DOCUMENT

COMPUTER SOFTWARE COSTS (Details 1) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
2018	$ 3,488
2019	13,950
2020	13,950
2021	2,880
Total	$ 34,268

XML 37 R27.htm IDEA: XBRL DOCUMENT

COMPUTER SOFTWARE COSTS (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
COMPUTER SOFTWARE COSTS (Details Narrative) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Useful life of computer software			3 years
Amortization of computer software costs	$ 3,488		$ 7,582

XML 38 R28.htm IDEA: XBRL DOCUMENT

ACCOUNTS PAYABLE (Details Narrative) - USD ($)	Jun. 30, 2018	Sep. 30, 2017	Jun. 30, 2017
Payables and Accruals [Abstract]
Accounts payable	$ 11,627
Accounts payable consist legal and consulting fees payable	$ 11,627

XML 39 R29.htm IDEA: XBRL DOCUMENT

PAYABLE TO AFFILIATES (Details) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Payable To Affiliates
Payable to affiliate	$ 98,837	$ 78,067
Total	$ 98,837	$ 78,067

XML 40 R30.htm IDEA: XBRL DOCUMENT

PAYABLE TO AFFILIATES (Details Narrative) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Payable To Affiliates
Advance from director	$ 500	$ 0

XML 41 R31.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS (Details Narrative)						3 Months Ended	9 Months Ended
RELATED PARTY TRANSACTIONS (Details Narrative)	May 30, 2018 shares	Dec. 28, 2017 USD ($)	Dec. 21, 2017 USD ($)	Dec. 11, 2017 Number	Nov. 20, 2017 Number	Jun. 30, 2018 USD ($)	Jun. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Advance from director						$ 500	$ 500	$ 0
Number of naturopathic learning management system sold \| Number				20	10
Proceeds from naturopathic learning management system sold		$ 50,000	$ 29,000
Deferred revenue from related parties						63,924	63,924
Number of shares granted \| shares	526,295
Director [Member]
Defined Benefit Plan Disclosure [Line Items]
Revenue from related parties						2,417	5,886
Deferred revenue from related parties						23,114	23,114
Chief Executive Officer [Member]
Defined Benefit Plan Disclosure [Line Items]
Revenue from related parties						4,167	9,190
Deferred revenue from related parties						$ 40,810	$ 40,810

XML 42 R32.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)	Jun. 21, 2018	May 16, 2018	Mar. 01, 2018	Nov. 30, 2016	Jun. 30, 2018	Sep. 30, 2017
Common stock, authorized					500,000,000	500,000,000
Common stock, par value (in dollars per share)					$ 0.001	$ 0.001
Previously common stock, authorized				75,000,000
Cash proceeds from issuance of shares		$ 10,050
Common stock, issued					161,405,000	150,150,000
Common stock, outstanding					161,405,000	150,150,000
Consulting Agreements [Member] \| Two Contractors [Member]
Common stock, authorized				500,000,000
Value of shares issued				$ 1,000,000
Number of shares issued, value				20,000
Value of new shares issued		50,000
Number of new shares issued, value		$ 50
Consulting Agreements [Member] \| Business Advisory Services [Member]
Value of shares issued	$ 50,000
Number of shares issued, value	85,000
Share Exchange Agreement [Member] \| Shareholders [Member]
Value of shares issued		105,000
Purchase price (in dollars per share)			$ 50
Cash proceeds from issuance of shares		$ 210	$ 40,464
Value of shares issued during the period		10,050,000
Common stock subscriptions, value					$ 10,050

XML 43 R33.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' DEFICIT (Details Narrative 1) - USD ($)		3 Months Ended		9 Months Ended
STOCKHOLDERS' DEFICIT (Details Narrative 1) - USD ($)	May 30, 2018	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Stock option granted	$ 1.70
Expiration date	May 30, 2023
Fair value of options granted	526,295
Risk free discount rate	2.79%
Volatility	106.00%
Dividend yield	0.00%
Stock based compensation		$ 526,295		$ 526,295
Employees and Directors [Member]
Expected Term	2 years 6 months
Non-employees [Member]
Expected Term	5 years
2018 Plan [Member]
Common stock capital reserve for future issuance	10,000,000
2018 Plan [Member] \| Two directors [Member]
Number for shares purchased	450,000
Term	P5Y
Exercise price options to purchase	$ 1.5

XML 44 R34.htm IDEA: XBRL DOCUMENT

EQUITY FINANCING AGREEMENT AND NOTE PAYABLE (Details) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Total	$ 40,000
Current portion	40,000
GHS Investments, Inc [Member]
Total	$ 40,000

XML 45 R35.htm IDEA: XBRL DOCUMENT

EQUITY FINANCING AGREEMENT AND NOTE PAYABLE (Details Narrative) - GHS Investments, Inc [Member] - Equity Financing Agreement and Registration Rights Agreement [Member] - USD ($)		1 Months Ended
	Jun. 05, 2018	Jun. 30, 2018
No of shares issued	20,000,000
Promissory note principal amount	$ 40,000
Interest rate	8.00%
Interest rate repaid	May 23, 2019
Accrued interest expense		$ 219

EXCEL 46 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 47 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 47 146 1 false 16 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://nhf.com.my/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED BALANCE SHEETS (Unaudited) Sheet http://nhf.com.my/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://nhf.com.my/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://nhf.com.my/role/CondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://nhf.com.my/role/CondensedStatementsOfCashFlows CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 5 false false R6.htm 00000006 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN Sheet http://nhf.com.my/role/NatureOfOperationsBasisOfPresentationAndGoingConcern NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN Notes 6 false false R7.htm 00000007 - Disclosure - SUMMARY OF SIGNIFCANT ACCOUNTING POLICIES Sheet http://nhf.com.my/role/SummaryOfSignifcantAccountingPolicies SUMMARY OF SIGNIFCANT ACCOUNTING POLICIES Notes 7 false false R8.htm 00000008 - Disclosure - PREPAID EXPENSE Sheet http://nhf.com.my/role/PrepaidExpense PREPAID EXPENSE Notes 8 false false R9.htm 00000009 - Disclosure - COMPUTER SOFTWARE COSTS Sheet http://nhf.com.my/role/ComputerSoftwareCosts COMPUTER SOFTWARE COSTS Notes 9 false false R10.htm 00000010 - Disclosure - ACCOUNTS PAYABLE Sheet http://nhf.com.my/role/AccountsPayable ACCOUNTS PAYABLE Notes 10 false false R11.htm 00000011 - Disclosure - PAYABLE TO AFFILIATES Sheet http://nhf.com.my/role/PayableToAffiliates PAYABLE TO AFFILIATES Notes 11 false false R12.htm 00000012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://nhf.com.my/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 00000013 - Disclosure - EQUITY FINANCING AGREEMENT AND NOTE PAYABLE Sheet http://nhf.com.my/role/EquityFinancingAgreementAndNotePayable EQUITY FINANCING AGREEMENT AND NOTE PAYABLE Notes 13 false false R14.htm 00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://nhf.com.my/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 14 false false R15.htm 00000015 - Disclosure - STOCKHOLDERS' DEFICIT Sheet http://nhf.com.my/role/StockholdersDeficit STOCKHOLDERS' DEFICIT Notes 15 false false R16.htm 00000016 - Disclosure - SUBSEQUENT EVENTS Sheet http://nhf.com.my/role/SubsequentEvents SUBSEQUENT EVENTS Notes 16 false false R17.htm 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables 18 false false R19.htm 00000019 - Disclosure - COMPUTER SOFTWARE COSTS (Tables) Sheet http://nhf.com.my/role/ComputerSoftwareCostsTables COMPUTER SOFTWARE COSTS (Tables) Tables http://nhf.com.my/role/ComputerSoftwareCosts 19 false false R20.htm 00000020 - Disclosure - PAYABLE TO AFFILIATES (Tables) Sheet http://nhf.com.my/role/PayableToAffiliatesTables PAYABLE TO AFFILIATES (Tables) Tables http://nhf.com.my/role/PayableToAffiliates 20 false false R21.htm 00000021 - Disclosure - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN (Details Narrative) Sheet http://nhf.com.my/role/NatureOfOperationsBasisOfPresentationAndGoingConcernDetailsNarrative NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN (Details Narrative) Details http://nhf.com.my/role/NatureOfOperationsBasisOfPresentationAndGoingConcern 21 false false R22.htm 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://nhf.com.my/role/SummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 00000024 - Disclosure - PREPAID EXPENSE (Details Narrative) Sheet http://nhf.com.my/role/PrepaidExpenseDetailsNarrative PREPAID EXPENSE (Details Narrative) Details http://nhf.com.my/role/PrepaidExpense 24 false false R25.htm 00000025 - Disclosure - COMPUTER SOFTWARE COSTS (Details) Sheet http://nhf.com.my/role/ComputerSoftwareCostsDetails COMPUTER SOFTWARE COSTS (Details) Details http://nhf.com.my/role/ComputerSoftwareCostsTables 25 false false R26.htm 00000026 - Disclosure - COMPUTER SOFTWARE COSTS (Details 1) Sheet http://nhf.com.my/role/ComputerSoftwareCostsDetails1 COMPUTER SOFTWARE COSTS (Details 1) Details http://nhf.com.my/role/ComputerSoftwareCostsTables 26 false false R27.htm 00000027 - Disclosure - COMPUTER SOFTWARE COSTS (Details Narrative) Sheet http://nhf.com.my/role/ComputerSoftwareCostsDetailsNarrative COMPUTER SOFTWARE COSTS (Details Narrative) Details http://nhf.com.my/role/ComputerSoftwareCostsTables 27 false false R28.htm 00000028 - Disclosure - ACCOUNTS PAYABLE (Details Narrative) Sheet http://nhf.com.my/role/AccountsPayableDetailsNarrative ACCOUNTS PAYABLE (Details Narrative) Details http://nhf.com.my/role/AccountsPayable 28 false false R29.htm 00000029 - Disclosure - PAYABLE TO AFFILIATES (Details) Sheet http://nhf.com.my/role/PayableToAffiliatesDetails PAYABLE TO AFFILIATES (Details) Details http://nhf.com.my/role/PayableToAffiliatesTables 29 false false R30.htm 00000030 - Disclosure - PAYABLE TO AFFILIATES (Details Narrative) Sheet http://nhf.com.my/role/PayableToAffiliatesDetailsNarrative PAYABLE TO AFFILIATES (Details Narrative) Details http://nhf.com.my/role/PayableToAffiliatesTables 30 false false R31.htm 00000031 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://nhf.com.my/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://nhf.com.my/role/RelatedPartyTransactions 31 false false R32.htm 00000032 - Disclosure - STOCKHOLDERS' DEFICIT (Details Narrative) Sheet http://nhf.com.my/role/StockholdersDeficitDetailsNarrative STOCKHOLDERS' DEFICIT (Details Narrative) Details http://nhf.com.my/role/StockholdersDeficit 32 false false R33.htm 00000033 - Disclosure - STOCKHOLDERS' DEFICIT (Details Narrative 1) Sheet http://nhf.com.my/role/StockholdersDeficitDetailsNarrative1 STOCKHOLDERS' DEFICIT (Details Narrative 1) Details http://nhf.com.my/role/StockholdersDeficit 33 false false R34.htm 00000034 - Disclosure - EQUITY FINANCING AGREEMENT AND NOTE PAYABLE (Details) Sheet http://nhf.com.my/role/EquityFinancingAgreementAndNotePayableDetails EQUITY FINANCING AGREEMENT AND NOTE PAYABLE (Details) Details http://nhf.com.my/role/EquityFinancingAgreementAndNotePayable 34 false false R35.htm 00000035 - Disclosure - EQUITY FINANCING AGREEMENT AND NOTE PAYABLE (Details Narrative) Sheet http://nhf.com.my/role/EquityFinancingAgreementAndNotePayableDetailsNarrative EQUITY FINANCING AGREEMENT AND NOTE PAYABLE (Details Narrative) Details http://nhf.com.my/role/EquityFinancingAgreementAndNotePayable 35 false false All Reports Book All Reports nhel-20180630.xml nhel-20180630.xsd nhel-20180630_cal.xml nhel-20180630_def.xml nhel-20180630_lab.xml nhel-20180630_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 52 0001214659-18-005459-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-18-005459-xbrl.zip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end